KRATOM CONSUMER PROTECTION
HB3127 creates the Kratom Consumer Protection Act and adds new restrictions on the manufacture, sale, distribution, labeling, and advertising of kratom products in Illinois. The bill defines kratom products and extracts, then prohibits adulterated or contaminated products, products with certain synthetic alkaloids, products with excessive 7-hydroxymitragynine, products with unsafe residual solvent levels, and products lacking adequate consumer directions and labeling. It also authorizes the Department of Public Health to assess administrative penalties against processors for violations, with penalties of up to $5,000 for a first offense and $10,000 for repeat offenses, deposited into the Food and Drug Safety Fund.
The bill also amends the Kratom Control Act to raise the minimum age for purchase, possession, sale, furnishing, and sampling of kratom from under 18 to under 21. In addition, it creates a 1,000-foot buffer zone around schools, playgrounds, recreation centers, child care centers, public parks, public libraries, and game arcades that admit persons under 21, where kratom advertising and sales would be prohibited. Violations of the age and location restrictions are treated as business offenses or misdemeanors under the existing kratom law framework.
If enacted, HB3127 would expand Illinois regulation of kratom by layering product-safety standards, labeling requirements, age restrictions, and location-based marketing and sales limits onto existing law. It would amend the Kratom Control Act and create new enforcement authority for the Department of Public Health, while also tying penalties to the Food and Drug Safety Fund. The bill would directly affect kratom processors, retailers, distributors, and advertisers, especially those operating near youth-oriented or public spaces.
No committee transcripts or recorded votes were provided, so there is no documented debate or roll-call history to indicate formal support or opposition. Based on the bill text alone, the measure appears framed as a consumer-protection and public-health bill, suggesting an intent to regulate rather than ban kratom. The absence of recorded discussion makes the overall sentiment difficult to gauge beyond the sponsor’s apparent concern with product safety and youth access.
The most likely points of contention are the higher age threshold of 21, the broad 1,000-foot advertising and sales restrictions, and the product standards that prohibit certain alkaloid levels and synthetic compounds. Retailers and kratom businesses may object to the compliance burden, enforcement risk, and the scope of the buffer zones, while supporters would likely emphasize consumer safety, preventing adulterated products, and reducing youth exposure. The bill also creates a good-faith reliance defense for processors, which may be intended to address concerns about liability for mislabeled inputs.